Regarding the subtype of breast cancer, 75 (53.2%) cases were luminal, 30 (21.3%) cases were luminal HER2, 16 (11.3%) cases were HER2-enriched, and 20 (14.2%) cases were TN breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.